Skip to main content
. Author manuscript; available in PMC: 2015 Jan 3.
Published in final edited form as: J Proteome Res. 2013 Dec 13;13(1):289–299. doi: 10.1021/pr400813u

Figure 5. Pre-validation of Periostin as a potential biomarker target through SDS-PAGE western blot analysis. (A) Six pancreatic cyst fluid samples were subjected to western blotting to validate the relative abundance of Periostin in mucinous and non-mucinous cyst fluid subtypes. (B) Densitometry quantitation of Periostin levels.

Figure 5

IPMN= intraductal papillary mucinous neoplasm

MCN= mucinous cystic neoplasm

SC= serous cystadenoma